title: The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
abstract: This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.
authors.affiliation: Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Verslype
authors.forename: E
authors.initials: E
authors.lastname: Van Cutsem
authors.forename: M
authors.initials: M
authors.lastname: Dicato
authors.forename: N
authors.initials: N
authors.lastname: Arber
authors.forename: J D
authors.initials: JD
authors.lastname: Berlin
authors.forename: D
authors.initials: D
authors.lastname: Cunningham
authors.forename: A
authors.initials: A
authors.lastname: De Gramont
authors.forename: E
authors.initials: E
authors.lastname: Diaz-Rubio
authors.forename: M
authors.initials: M
authors.lastname: Ducreux
authors.forename: T
authors.initials: T
authors.lastname: Gruenberger
authors.forename: D
authors.initials: D
authors.lastname: Haller
authors.forename: K
authors.initials: K
authors.lastname: Haustermans
authors.forename: P
authors.initials: P
authors.lastname: Hoff
authors.forename: D
authors.initials: D
authors.lastname: Kerr
authors.forename: R
authors.initials: R
authors.lastname: Labianca
authors.forename: M
authors.initials: M
authors.lastname: Moore
authors.forename: B
authors.initials: B
authors.lastname: Nordlinger
authors.forename: A
authors.initials: A
authors.lastname: Ohtsu
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
authors.forename: H-J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
authors.forename: J
authors.initials: J
authors.lastname: Tabernero
authors.forename: C
authors.initials: C
authors.lastname: van de Velde
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000628:therapy*